Jefferson Health is proud to be the home of the first LGBTQIA+ affirming primary care dedicated to older adults in the Philadelphia region at our Center for Healthy Aging. Read more from Philadelphia Gay News: brnw.ch/21wDXzL

Check out this stellar Teaching Tuesday on APS! What pearls do you have about treating patients with APS?

Neat paper describes clinical inertia and opportunities to do better in hypertension management! Predictors of treatment intensification in uncontrolled... : Journal of Hypertension journals.lww.com/jhypertension/…

💊Women with atherosclerotic CVD aren't taking #statins as often as men Part of our #HealioExclusive explores the reasons why Read more below👇 Erin D. Michos, M.D. healio.com/news/cardiolog…

Wow! I needed this today

Excited to share our new review article published in Journal of Cardiovascular Pharmacology reviewing the safety/efficacy of #polypill for CV risk-reduction. Special thanks to co-authors Thomas Jefferson University PharmD students (Ana & Audrey) and Dr. Jason Ojeda from Jefferson Health 🥳 journals.lww.com/cardiovascular…

More data supporting the safety of #polypill containing ARB/CCB/Statin pubmed.ncbi.nlm.nih.gov/37814541/

The issue of Lp(a) and platelet fnx has not had lots of attention. In view of the lack of effects of Lp(a) on fibrinolysis in vivo, we make a case that Lp(a)'s effects on platelet function may explain some its atherothrombosis. Harpreet Bhatia Paul Lacaze urldefense.com/v3/__https://r…$

The most effective GLP-1-based medicine to date, Tirzepatide, approved by U.S. FDA for treatment of people living with #obesity and weight management, marketed as Zepbound, by Eli Lilly and Company 2.5-15mg doses, 20% less expensive than 2.4 semaglutide ow investor.lilly.com/news-releases/…

#JustPublished SimPub #AHA23 #CIRCAHA23: Novel race-free prediction equations, AHA Predicting Risk of CVD EVENTs (PREVENT), include kidney function and prediction of HF for short- and long-term risk of total CVD #AHAJournals Sadiya Khan @JoeCoresh ahajrnls.org/462rw4Y

Could identifying and addressing social health needs lead to increased medication and #statin adherence? read.qxmd.com/read/37889865

Risk of Pancreatitis With Incretin Therapies vs TZDs in the VA journals.sagepub.com/doi/10.1177/10…

FOMO is 💯 this weekend as I’m missing both #AHA23 and #ACCPAM23 😞, but at least I can follow along via Twitter (or “X”).

More actions of glucagon on #insulin secretion and clearance in humans Diabetes, an ADA research journal 🧪 diabetesjournals.org/diabetes/artic…

Will we see headlines that say, "GLP1 meds increase the risk of thyroid cancer by 1.5x" but failing to acknowledge the overall low incidence rate vs placebo (0.16% vs 0.08%) Daniel J Drucker dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

TZP 5 mg ~ Sema 2 mg. TZP 10 or 15 --> superior HbA1c and weight loss than Sema 2 mg Adjusted Indirect Treatment Comparison (Unfair but no more guessing?) dom-pubs.onlinelibrary.wiley.com/doi/full/10.11…

This phase 2 trial observed the impact of retatrutide on obesity in over 300 patients and was shown to be effective! Retatrutide works on three receptors: GLP-1, GIP, and glucagon. Tell us what you think about this new agent! #AmCare #ACCP #Pharmacy

Something I look forward to each year is reading the guidelines to see the newest updates to diabetes care and the evolving standards of care! #ADASoC

Learn about the role of a lipid clinic in promoting guideline-directed therapy and other innovative lipid management strategies for ASCVD risk reduction from Seth Martin.

Come join me in Philly! Jefferson College of Pharmacy has openings for 2 faculty positions. recruit.jefferson.edu/psp/hcmp/EMPLO…